Clinical Trial Update: Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) [Phase 2]

View source ↗

Summary

Phase 2 trial of imatinib mesylate in children with Philadelphia chromosome-positive acute lymphoblastic leukemia has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Renato Melaragno | Conditions: Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) | Phase 2 | Status: SUSPENDED